Temporal Interference Stimulation Targeting Prefrontal Cortex May Alleviate Depression Symptoms

Transcranial TIS targeting vmPFC enhances reward learning and may improve symptoms of subclinical depression
Adobe Stock
Adobe Stock
Published on: 

FRIDAY, Nov. 20, 2026 (HealthDay News) -- Transcranial temporal interference stimulation (tTIS) targeting the ventromedial prefrontal cortex (vmPFC) enhances reward learning and may alleviate symptoms of depression, according to a study published online Nov. 18 in Science Translational Medicine.

Feixue Wang, M.D, from the Chinese Academy of Sciences in Beijing, and colleagues used an instrumental learning paradigm to resolve the spatio-spectral-temporal neural dynamics of reward processing, informing development of a tTIS protocol. To establish the frequency-selective neuromodulation of reward learning and elucidate the underlying neural mechanism in healthy adults, a vmPFC-targeted tTIS protocol engaging the frontostriatal circuit was developed. The antidepressant effects were then explored in a randomized controlled trial involving 69 patients with subclinical depression.

The researchers identified a bidirectional excitatory-inhibitory loop between the vmPFC and ventral striatum, encoding reward prediction errors (RPEs) and scaling with individual learning rates in healthy adults. VmPFC alpha and theta frequencies tracked RPEs; no corresponding pattern was seen for punishment processing. Reward learning was enhanced and frontostriatal connectivity was reshaped with alpha-frequency tTIS (10 Hz) over vmPFC; no effect was seen for theta frequency tTIS (5 Hz). In the randomized trial, three daily sessions of alpha-frequency tTIS alleviated subclinical depressive symptoms; at seven-day follow-up, delayed benefits were seen.

"Our findings suggest that tTIS10Hz applied to the vmPFC can enhance reward learning and shows potential for alleviating depressive symptoms in a subclinical cohort," the authors write. "By bridging mechanistic insights with therapeutic innovation, this work advances circuit-targeted neuromodulation for depression and related disorders characterized by reward dysfunction."